Palliative Care News

Despite the benefits and accessibility of administering cancer medications and fluids subcutaneously vs. intravenously, U.S. facilities appear to underuse this delivery method, according to a research letter published in JAMA Oncology.

Palliative care specialist services provided around the time of cancer surgery with curative intent failed to significantly improve patient outcomes, results of a randomized study showed.

Oncology drug costs overall, and immunotherapy costs specifically, drove Medicare spending increases for outpatient end-of-life cancer care, according to research in International Journal of Radiation Oncology, Biology, Physics.

Nurse-led primary palliative care led to significantly higher uptake of advance care planning vs. standard care among patients with advanced cancers, according to study results in JCCN — Journal of the National Comprehensive Cancer Network.

Increased awareness of the quality-of-life harm and financial burden associated with continued cancer treatment at the end of a patient’s life has led professional societies to promote reduced systemic anticancer therapy at this stage.

The risk for suicide remains elevated among individuals diagnosed with cancer compared with the general population, despite a downward trend over the last 2 decades, a recent study found.

Clinicians in the United States prescribed fewer opioid medications for cancer pain and chronic noncancer pain between 2012 and 2019, according to a study published in PLOS ONE.

The medical profession has increasingly embraced palliative care as a key component of patient-centered therapy.

Several forms of integrative medicine can effectively relieve pain caused by cancer and its treatments, according to study results.

Psilocybin is one the most well-known psychedelics — and one of the most widely touted for its potential to confer benefit in the medical setting.